Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions

Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions

Background: The incorporation of genomic testing into clinical practice constitutes an opportunity to improve patients’ lives, as it makes possible the implementation of innovative, individualized clinical interventions that maximize efficacy and/or minimize the risk of adverse drug reactions. In or...

Full description

Bibliographic Details
Main Authors: Stavros Simeonidis, Stefania Koutsilieri, Athanassios Vozikis, David N. Cooper, Christina Mitropoulou, George P. Patrinos
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Pharmacology
Subjects:
economic evaluation
pricing
reimbursement
genetic and genomic tests
personalized medicine
quality of life
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00830/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00830/full

Similar Items